Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist

JP Salameh, PM Bossuyt, TA McGrath, BD Thombs… - bmj, 2020 - bmj.com
Systematic reviews of diagnostic test accuracy (DTA) studies are fundamental to the
decision making process in evidence based medicine. Although such studies are regarded …

Viral hepatitis and pregnancy

NA Terrault, MT Levy, KW Cheung… - Nature reviews …, 2021 - nature.com
The management of viral hepatitis in the setting of pregnancy requires special consideration.
There are five liver-specific viruses (hepatitis A, B, C, D, E), each with unique epidemiology …

Position statement from the International Society for Prenatal Diagnosis on the use of non‐invasive prenatal testing for the detection of fetal chromosomal conditions in …

L Hui, K Ellis, D Mayen, MD Pertile… - Prenatal …, 2023 - Wiley Online Library
Key points What is already known about this topic? In 2015, the International Society for
Prenatal Diagnosis (ISPD) published its first position statement on the use of non‐invasive …

Prenatal diagnosis: screening and diagnostic tools

LM Carlson, NL Vora - Obstetrics and Gynecology Clinics, 2017 - obgyn.theclinics.com
Approximately 3% to 5% of pregnancies are complicated by birth defects or genetic
disorders. 1 Chromosomal abnormalities are present in approximately 1 in 150 live births, 2 …

Management of 46, XY differences/disorders of sex development (DSD) throughout life

AB Wisniewski, RL Batista, EMF Costa… - Endocrine …, 2019 - academic.oup.com
Differences/disorders of sex development (DSD) are a heterogeneous group of congenital
conditions that result in discordance between an individual's sex chromosomes, gonads …

[HTML][HTML] Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences

A Cernat, C De Freitas, U Majid, F Trivedi… - BMC pregnancy and …, 2019 - Springer
Background Non-invasive prenatal testing (NIPT) can be used to accurately detect fetal
chromosomal anomalies early in pregnancy by assessing cell-free fetal DNA present in …

Analysis of cell‐free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population–a systematic …

E Iwarsson, B Jacobsson, J Dagerhamn… - Acta obstetricia et …, 2017 - Wiley Online Library
Introduction The aim of this study was to review the performance of non‐invasive prenatal
testing (NIPT) for detection of trisomy 21, 18 and 13 (T21, T18 and T13) in a general …

Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

M Badeau, C Lindsay, J Blais… - Cochrane Database …, 2017 - cochranelibrary.com
Background Common fetal aneuploidies include Down syndrome (trisomy 21 or T21),
Edward syndrome (trisomy 18 or T18), Patau syndrome (trisomy 13 or T13), Turner …

[HTML][HTML] Antenatal screening for chromosomal abnormalities

KO Kagan, J Sonek, P Kozlowski - Archives of gynecology and obstetrics, 2022 - Springer
Screening for chromosomal disorders, especially for trisomy 21, has undergone a number of
changes in the last 50 years. Today, cell-free DNA analysis (cfDNA) is the gold standard in …

The clinical utility of genome‐wide non invasive prenatal screening

F Fiorentino, S Bono, F Pizzuti, S Duca… - Prenatal …, 2017 - Wiley Online Library
Objective In this study, we expanded conventional cell‐free fetal DNA (cfDNA)‐based non‐
invasive prenatal testing (NIPT) to cover the entire genome. We aimed to compare the …